Poliovirus Therapy for Glioblastoma has Three-Year Survival Rate of 21 Percent | Duke Today
Brain immunology and immunotherapy in brain tumours | Nature Reviews Cancer
glioblastoma | Duke Cancer Institute
Poliovirus Therapy Induces Immune Responses Against Cancer | Duke Cancer Institute
Duke Neurosurgery granted funding to study novel vaccine for pediatric brain tumors | Duke Department of Neurosurgery
vaccine | Duke Cancer Institute
St. Lucie families cautious about cancer treatment 'breakthrough'
Poliovirus Therapy Shows Potential as Cancer Vaccine in Lab Studies | Duke Health
Vaccine-based immunotherapeutic approaches to gliomas and beyond | Nature Reviews Neurology
Modified polio vaccine helps fight deadly brain tumors
Modified polio vaccine helps fight deadly brain tumors
glioblastoma | Duke Cancer Institute
WATCH: Teen battling cancer sings with Duke Health nurse | wcnc.com
Duke's Brain Tumor Center Marks 85 Years | Duke Department of Neurosurgery
Immunomic Therapeutics Assumes Sponsorship of ATTAC II IND for a Brain Cancer Vaccine — Duke OTC
Duke Researchers Find Simpler, More Effective Cancer Vaccine Approach | Duke Health
Duke SPORE in Brain Cancer | TRP
Vaccine modalities employed in GBM (peptide, neoantigen, DC). Methods... | Download Scientific Diagram
Brain Tumor Research Featured in People Magazine | Duke Health
A Promising Brain Tumor Vaccine Is On Its Way - Scientific Animations
Sandra Hillburn Receives Her 100th CMV Vaccine | Tisch Brain Tumor Center
Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed | Duke Cancer Institute
Tetanus Vaccine Helps Improve Survival in People with Glioblastoma | Duke Health
